Synaptogenix | 10-Q: Q3 2024 Earnings Report

SECNov 12 17:05 ET · Announcements

Express News | Synaptogenix Files for Prospectus Related to Resale or Other Disposition From Time to Time of up to 11.9 Mln Shares of Common Stock- SEC Filing

ReutersOct 10 17:14 ET

Telesis Bio TBIO Delisting; Synaptogenix SNPX Offering

BioPharmCatalystSep 11 16:01 ET

Synaptogenix Enters Into Securities Purchase Agreements For A $5M Financing With Existing Investors Involving The Sale Of 5,000 Shares Of Its Newly Issued Series C Convertible Preferred Stock, With A Stated Value Of $1,000 Per Share; The Shares Of...

BenzingaSep 11 09:07 ET

Express News | Synaptogenix Announces $5.0 Million Financing

ReutersSep 11 09:00 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaSep 2 08:05 ET